DCGO vs. QSI, AGFS, ORGN, LTCH, PNTG, INNV, WGS, TALK, SHCR, and PIII
Should you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Quantum-Si (QSI), AgroFresh Solutions (AGFS), Origin Materials (ORGN), Latch (LTCH), The Pennant Group (PNTG), InnovAge (INNV), GeneDx (WGS), Talkspace (TALK), Sharecare (SHCR), and P3 Health Partners (PIII).
DocGo (NASDAQ:DCGO) and Quantum-Si (NASDAQ:QSI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.
In the previous week, DocGo and DocGo both had 2 articles in the media. DocGo's average media sentiment score of 1.26 beat Quantum-Si's score of 1.25 indicating that DocGo is being referred to more favorably in the media.
56.4% of DocGo shares are owned by institutional investors. Comparatively, 39.9% of Quantum-Si shares are owned by institutional investors. 2.7% of DocGo shares are owned by company insiders. Comparatively, 30.0% of Quantum-Si shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
DocGo currently has a consensus price target of $7.75, indicating a potential upside of 145.25%. Quantum-Si has a consensus price target of $2.67, indicating a potential upside of 68.78%. Given DocGo's stronger consensus rating and higher possible upside, research analysts clearly believe DocGo is more favorable than Quantum-Si.
DocGo has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.
DocGo has a net margin of 2.98% compared to Quantum-Si's net margin of -7,145.76%. DocGo's return on equity of 6.20% beat Quantum-Si's return on equity.
DocGo received 37 more outperform votes than Quantum-Si when rated by MarketBeat users. Likewise, 73.21% of users gave DocGo an outperform vote while only 66.67% of users gave Quantum-Si an outperform vote.
DocGo has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Quantum-Si has a beta of 3.04, suggesting that its stock price is 204% more volatile than the S&P 500.
Summary
DocGo beats Quantum-Si on 14 of the 17 factors compared between the two stocks.
Get DocGo News Delivered to You Automatically
Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
